Concepedia

Shamkant Mulgaonkar

SM

28

Publications

2.6K

Citations

23

H-Index

1996

Active since

Affiliations

Saint Barnabas Medical Center(Current)

Hospital do Rim e Hipertensão

University of California, San Francisco

Novartis (Switzerland)

Medical University of South Carolina

Shamkant Mulgaonkar is an author at Saint Barnabas Medical Center specializing in kidney transplant, medicine, and nephrology.

Top concepts

Publications per year

1996–2019

28

Publications

28

Alemtuzumab Induction in Renal Transplantation

Michael J. Hanaway, E. Steve Woodle, Shamkant Mulgaonkar et al. · New England Journal of Medicine · 2011 · 374 citations

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

Julio Pascual, Stefan P. Berger, Oliver Witzke et al. · Journal of the American Society of Nephrology · 2018 · 239 citations · Full text

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

Marc I. Lorber, Shamkant Mulgaonkar, Khalid M.H. Butt et al. · Transplantation · 2005 · 231 citations

FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

Hélio Tedesco‐Silva, Georges Mourad, Barry D. Kahan et al. · Transplantation · 2004 · 216 citations

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

Matthew R. Weir, Shamkant Mulgaonkar, Laurence Chan et al. · Kidney International · 2010 · 183 citations

, , +11

Rows per page

1–5 of 28